-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Metabolic Regulation and Implications for Red Cells

PhD Trainee
Sponsor: Scientific Committee on Red Cell Biology
Program: Scientific Program
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Fundamental Science, Genetic Disorders, bioinformatics, hematopoiesis, Diseases, Lymphoid Malignancies, metabolism, computational biology, Biological Processes, Technology and Procedures, Metabolic Disorders, pathogenesis
Monday, December 12, 2022: 4:30 PM-5:45 PM
275-277 (Ernest N. Morial Convention Center)

Description:
This session will provide an overview of how metabolic control can be regulated in different ways. The speakers will discuss how metabolic regulation can impact normal hematopoiesis and how it can contribute to disease. In addition, the speakers will also discuss how this process can impact the process of red blood cell production of erythropoiesis. This session will provide attendees with a broad perspective on metabolic regulation and also help guide individuals on how metabolism can impact blood cell production in health and disease. 

 

Dr. Navdeep Chandel will discuss data on how mitochondrial electron transport chain is necessary for hematopoietic stem cell function and transformation by oncogene Notch.   

 

Dr. Leonard Zon will discuss the control of metabolic pathways in red blood cells by transcription. He will focus on a chromatin factor, TIF1g, that controls coenzyme Q synthesis and the interaction of ferroptosis and metabolism. Dr. Zon will also discuss how stress and reactive oxygen species regulate erythropoiesis. 

 

Dr. Xu will discuss recent findings on metabolic profiles and mechanisms, in particular a glutamine metabolic switch, that function to control normal and ineffective erythropoiesis.

Chair:
Vijay G. Sankaran, MD, PhD, Boston Children's Hospital
Disclosures:
Sankaran: Sana Biotechnology: Consultancy; Novartis: Consultancy; Branch Biosciences: Consultancy; Forma Therapeutics: Consultancy; Cellarity: Consultancy; Ensoma: Consultancy.
This session will provide an overview of how metabolic control can be regulated in different ways. The speakers will discuss how metabolic regulation can impact normal hematopoiesis and how it can contribute to disease. In addition, the speakers will also discuss how this process can impact the process of red blood cell production of erythropoiesis. This session will provide attendees with a broad perspective on metabolic regulation and also help guide individuals on how metabolism can impact blood cell production in health and disease. 

 

Dr. Navdeep Chandel will discuss data on how mitochondrial electron transport chain is necessary for hematopoietic stem cell function and transformation by oncogene Notch.   

 

Dr. Leonard Zon will discuss the control of metabolic pathways in red blood cells by transcription. He will focus on a chromatin factor, TIF1g, that controls coenzyme Q synthesis and the interaction of ferroptosis and metabolism. Dr. Zon will also discuss how stress and reactive oxygen species regulate erythropoiesis. 

 

Dr. Xu will discuss recent findings on metabolic profiles and mechanisms, in particular a glutamine metabolic switch, that function to control normal and ineffective erythropoiesis.

Navdeep S. Chandel, PhD

Medicine, Northwestern University Chicago, Chicago, IL

Leonard I. Zon, MD

Harvard University, Boston, MA

Jian Xu, PhD

Children's Research Institute, University of Texas Southwestern, Dallas, TX

See more of: Scientific Program